National Asset Management, Inc. Anixa Biosciences Inc Transaction History

National Asset Management, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 21, 2023	SELL	$3.78 - $5.81 $3,780 - $5,810	-1,000 Reduced 6.17%	15,200 $64,000
Q3 2022 Nov 14, 2022	BUY	$2.81 - $6.15 $45,522 - $99,630	16,200 New	16,200 $80,000

5.56M

21K

6.7K

Ticker ANIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,661,700
Market Cap $96.6M
Description
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on National Asset Management, Inc. with notifications on news.